Stock Analiz

Bicycle Therapeutics PLC (BCYC) stock forecast and price target

Price $3.37 · data as of November 13, 2026

12-month price target

Average target$9.17
Upside / downside+172.0%
Analysts6
ConsensusBuy
Low $5.00Average $9.17High $14.00

Gold marker: average target · white marker: today’s price ($3.37)

Analyst ratings

Strong buy 2Buy 4Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.26+28.4%$38M
Next fiscal year
ends December 31, 2027
$-2.40−6.3%$5M
Next quarter
ends December 31, 2026
$-0.52−78.9%$3M
Quarter after
ends March 31, 2027
$-0.61+30.3%$1M

Consensus of the analysts covering Bicycle Therapeutics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Bicycle Therapeutics stock price target?

The average 12-month target from 6 analysts is $9.17, 172.0% above the current price of $3.37 Targets range from $5.00 to $14.00.

Is Bicycle Therapeutics a buy according to analysts?

The consensus rating is “Buy” (2 strong buy, 4 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Bicycle Therapeutics expected to earn?

Analysts expect EPS of $-2.26 for the fiscal year ending December 31, 2026 and $-2.40 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.